Topics

Catalent, Zumutor Biologics Ink Mfg. Agreement

05:46 EST 11 Feb 2020 | Contract Pharma

Catalent to provide process optimization and drug substance manufacturing from its Madison site for Zumutor’s lead candidate, ZM008

Original Article: Catalent, Zumutor Biologics Ink Mfg. Agreement

NEXT ARTICLE

More From BioPortfolio on "Catalent, Zumutor Biologics Ink Mfg. Agreement"

Quick Search

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...